Marker Therapeutics | 3:首次持股聲明-高管 Lurier Eliot M
2023/07/05 16:22 (美東)
Marker Therapeutics | 4:持股變動聲明-董事 Eansor Norman David
2023/06/08 21:35 (美東)
Marker Therapeutics | 4:持股變動聲明-董事 Knobil Katharine
2023/06/08 21:34 (美東)
Marker Therapeutics | 4:持股變動聲明-董事 Wilson John Robert
2023/06/08 21:33 (美東)
Marker Therapeutics | 4:持股變動聲明-董事 ELMS STEVE
2023/06/08 21:32 (美東)
Marker Therapeutics | 4:持股變動聲明-高管 Vera Juan
2023/05/11 18:10 (美東)
Marker Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Aisling Capital IV, LP(5.46%),Steve Elms(5.46%)等
2023/03/03 16:30 (美東)
Marker Therapeutics | 4:持股變動聲明
2023/03/01 16:52 (美東)
Marker Therapeutics | 4:持股變動聲明
2023/03/01 16:51 (美東)
Marker Therapeutics | 4:持股變動聲明
2023/03/01 16:50 (美東)
Marker Therapeutics | 4:持股變動聲明
2023/03/01 16:49 (美東)
Marker Therapeutics | 4:持股變動聲明
2023/03/01 16:48 (美東)
Marker Therapeutics | 4:持股變動聲明
2023/03/01 16:47 (美東)
Marker Therapeutics | 4:持股變動聲明
2022/05/26 16:12 (美東)
Marker Therapeutics | 4:持股變動聲明
2022/05/26 16:10 (美東)
Marker Therapeutics | 4:持股變動聲明
2022/05/26 16:10 (美東)
Marker Therapeutics | 4:持股變動聲明
2022/05/26 16:09 (美東)
Marker Therapeutics | 4:持股變動聲明
2022/05/26 16:08 (美東)
Marker Therapeutics | 4:持股變動聲明
2022/03/28 21:06 (美東)
Marker Therapeutics | 4:持股變動聲明
2022/03/28 21:04 (美東)
暫無數據
暫無數據